XML 94 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
SeriesA and Series B Redeemable Convertible Preferred Stock
Common Stock
SeriesA and Series B Redeemable Convertible Preferred Stock
Additional Paid-in Capital
SeriesA and Series B Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Comprehensive Income (loss)
Accumulated Deficit
Total
Balance at beginning of period at Dec. 31, 2017         $ 50   $ (25) $ 25
Balance at beginning of period (shares) at Dec. 31, 2017       2,286,200        
Increase (Decrease) in Stockholders' Equity                
Beneficial conversion feature related to related party convertible notes         401     401
Issuance of common stock in exchange for process research and development         1,815     1,815
Issuance of common stock in exchange for process research and development (in shares)       2,880,612        
Foreign currency translation adjustment           $ 2   2
Net loss             (15,529) (15,529)
Balance at end of period at Dec. 31, 2018         2,266 2 (15,554) (13,286)
Balance at end of period (shares) at Dec. 31, 2018       5,166,812        
Increase (Decrease) in Stockholders' Equity                
Conversion of related party convertible notes into common stock         651     651
Conversion of related party convertible notes into common stock (in shares)       1,565,300        
Exercise of stock options         1     1
Exercise of stock options (in shares)       1,143        
Conversion of Series A and B redeemable convertible preferred stock into common stock $ 1 $ 40,911 $ 40,912          
Conversion of Series A and B redeemable convertible preferred stock into common stock (in shares) 8,264,613              
Extinguishment of related party convertible notes net of substantial premium         732     732
Stock–based compensation         118     118
Issuance of common stock and warrants to former Gemphire stockholders and effect of reverse asset acquisition       $ 15 4,451     4,466
Issuance of common stock and warrants to former Gemphire stockholders and effect of reverse asset acquisition (in shares)       594,850        
Foreign currency translation adjustment           10   10
Net loss             (21,312) (21,312)
Balance at end of period at Dec. 31, 2019       $ 16 $ 49,130 $ 12 $ (36,866) $ 12,292
Balance at end of period (shares) at Dec. 31, 2019       15,592,718